World Breast Cancer Research Day

World Breast Cancer Research Day highlights progress in drug development for the disease, emphasizing the focus on metastatic stages to improve survival and symptom management.

Key insights:

743 ongoing industry-led, FDA-track clinical programs
Top targets: HER2, TROP2, PD1/PD-L1 pathway
52 Phase 3 drugs await FDA approval for breast cancer

While early-stage breast cancer is often curable, advanced metastatic disease presents a significant challenge. The industry prioritizes established targets, but more biomarkers for early detection and treatment are necessary.

Discover more in the full Intelligencia AI research report on breast cancer drug development's present and future.

Vendor:: Intelligencia AI
Posted:: Aug 28, 2024
Published:: Aug 29, 2024
Format:: PDF
Type:: White Paper

Already a Bitpipe member? Log in here

Download this White Paper!

Corporate Email Address:
You forgot to provide an Email Address.

This email address doesn’t appear to be valid.

Please provide a Corporate Email Address.

This email address is already registered. Please log in.
First Name:
You forgot to provide your first name.
Last Name:
You forgot to provide your last name.
Company Name:
You forgot to provide a company name.
Job Title:
You forgot to provide a job title.
Seniority:
You forgot to select your seniority.
Job Function:
You forgot to select your job function.
# of employees:
You did not select the number of employees at your company.
Industry:
You did not select which industry you are in.
Sub-Industry:
You did not select which industry you are in.
Address 1:
You did not provide a full local address.
Address 2:
City/Town:
You did not provide a full local address.
Country:
You did not select the country you are from.
State/Province:

You did not provide a full local address.
Zip/Postal Code:
You did not provide a full local address.
Phone:
You forgot to provide a phone number.

This phone number format is not recognized. Please check the country and number.
- I agree to TechTarget’s Terms of Use, Privacy Policy, and the transfer of my information to the United States for processing to provide me with relevant information as described in our Privacy Policy.
Please check the box if you want to proceed.
- I agree to my information being processed by TechTarget and its Partners to contact me via phone, email, or other means regarding information relevant to my professional interests. I may unsubscribe at any time.
Please check the box if you want to proceed.